"Vasculitis, Central Nervous System" - Books

Result Filters

Results: 1 to 20 of 96 books (420 items)

<< First< Prev

Page of 5

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

Top results in this book Table of Contents

Select item 46628042.

Clinical Review Report: Tocilizumab (Actemra): (Hoffmann-La Roche Limited): Indication: For the treatment of giant cell arteritis (GCA) in adult patients [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr.

Top results in this book Table of Contents

Select item 46657083.

Pharmacoeconomic Review Report: Tocilizumab (Actemra): (Hoffman-La Roche Limited): Indication: For the treatment of giant cell arteritis (GCA) in adult patients [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr.

Top results in this book Table of Contents

Select item 44650644.

Autoimmunity: From Bench to Bedside [Internet].

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors.

Bogota (Colombia): El Rosario University Press; 2013 Jul 18.

Top results in this book Table of Contents

Select item 14589845.

GeneReviews® [Internet].

Adam MP, Bick S, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2026.

Top results in this book Table of Contents

Select item 46471226.

CADTH Canadian Drug Expert Committee Recommendation: Tocilizumab (Actemra – Hoffmann-La Roche Limited): Indication: Giant cell arteritis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar 29.

Top results in this book Table of Contents

Select item 53827727.

Skills in Rheumatology [Internet].

Almoallim H, Cheikh M, editors.

Singapore: Springer; 2021.

Top results in this book Table of Contents

Select item 30760208.

Adverse Effects of Vaccines: Evidence and Causality.

Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.

Washington (DC): National Academies Press (US); 2011 Aug 25.

Top results in this book Table of Contents

Select item 14453429.

Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition.

Walker HK, Hall WD, Hurst JW, editors.

Boston: Butterworths; 1990.

Top results in this book Table of Contents

Select item 537033010.

Selected Immune Disorders and Disability.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Selected Immune Disorders and Disability.

Washington (DC): National Academies Press (US); 2022 May 24.

Top results in this book Table of Contents

Select item 521860011.

Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].

Gidengil C, Goetz MB, Maglione M, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)

Top results in this book Table of Contents

Select item 531965612.

NEUROLOGY OF COVID–19 [Internet].

Priori A, editor.

Milano: Milano University Press; 2021 Feb.

Top results in this book Table of Contents

Select item 532506813.

Enhancing NIH Research on Autoimmune Disease.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee for the Assessment of NIH Research on Autoimmune Diseases.

Washington (DC): National Academies Press (US); 2022 Jun 2.

Top results in this book Table of Contents

Select item 558405614.

Faricimab (Vabysmo): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jan.

Top results in this book Table of Contents

Select item 166869015.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Top results in this book Table of Contents

Select item 559234416.

Atezolizumab (Tecentriq): CADTH Reimbursement Review: Therapeutic area: Non–small cell lung cancer [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Dec.

Top results in this book Table of Contents

Select item 553983417.

Toxicological Profile for Iodine.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2004 Apr.

Top results in this book Table of Contents

Select item 145398418.

Use of Dietary Supplements by Military Personnel.

Institute of Medicine (US) Committee on Dietary Supplement Use by Military Personnel; Greenwood MRC, Oria M, editors.

Washington (DC): National Academies Press (US); 2008.

Top results in this book Table of Contents

Select item 567236819.

An Inventory of Rare Disease Registries in the Canadian Landscape: Environmental Scan [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Aug.

Top results in this book Table of Contents

Select item 521881420.

Stroke [Internet].

Dehkharghani S, editor.

Brisbane (AU): Exon Publications; 2021 Jun 18.

Top results in this book Table of Contents

<< First< Prev

Page of 5

Next >Last >>

Supplemental Content

Images search in Bookshelf

Figure 12Therapeutic algorithm for treatment of extra-glandular manifestations in Sjögren’s syndrome.

Proposed therapeutic algorithm for treatment of the main extraglandular manifestations of SS. Available data for treatment of extraglandular SS symptoms come from nonanalytical studies, such as retrospective series or case reports (evidence level 3, on a scale of 1–4) representing the lowest strength of recommendation (grade D, rated from A–D) according to the grading recommendations of Harbour and Miller. The sole exception is a RCT using rituximab, which showed a reduction of the number of reported extraglandular manifestations compared with placebo (though the number of patients was too small to provide a specific recommendation). Corticosteroids should be used at the minimum dose and length of time necessary. Classification of drugs as first-line, second-line and third-line therapies is based on the number of case reports that have shown them to be effective and the authors’ experience. No data are available on immunosuppressive maintenance therapy; thus, regimens similar to those used in other autoimmune diseases (systemic lupus erythematosus, vasculitis) are recommended. CNS: central nervous system; IVIg: intravenous immunoglobulin; SS: Sjögren’s syndrome. Adapted from Ramos-Casals et al. (219), with permission.

Sjögren’s syndrome.

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18.